Back to News
research

New Strong Sell Stocks for April 8th

Zacks
Loading...
3 min read
0 likes
⚡ Quantum Brief
Three stocks—Air France-KLM (AFLYY), Agios Pharmaceuticals (AGIO), and Alliance Resource Partners (ARLP)—were added to the Zacks Rank #5 "Strong Sell" list on April 8, 2025. Air France-KLM’s earnings estimates dropped 23.1% in 60 days, reflecting declining confidence in the airline’s passenger, cargo, and maintenance services amid industry challenges. Agios Pharmaceuticals saw its earnings outlook slashed by 18.9%, signaling struggles in its rare genetic disorder drug development pipeline and market adoption. Alliance Resource Partners, a coal producer, faced a 7.9% earnings downgrade, highlighting weakened demand from U.S. utilities and industrial buyers amid energy transition pressures. The revisions underscore broader sectoral risks, with analysts sharply lowering projections for aviation, biopharma, and fossil fuel industries in early April 2025.
AI Audio Summary
0:00 / 0:00
Click to play
gabriel-vasiliu-mdzxj9Ea7JM-unsplash.jpg
Quantum News · Media Library

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Stocks New Strong Sell Stocks for April 8th April 08, 2025 — 06:24 am EDT Written by Zacks Equity Research for Zacks-> Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:Air France-KLM AFLYY is an airline company with core business is passenger transport, cargo transport, and aircraft maintenance services.

The Zacks Consensus Estimate for its current year earnings has been revised 23.1% downward over the last 60 days.Agios Pharmaceuticals AGIO is a biopharmaceutical company focused on the development of treatments for rare genetic metabolic disorders, a subset of orphan genetic metabolic diseases.

The Zacks Consensus Estimate for its current year earnings has been revised 18.9% downward over the last 60 days.Alliance Resource Partners ARLP is a diversified producer and marketer of coal to major U.S. utilities and industrial users.

The Zacks Consensus Estimate for its current year earnings has been revised almost 7.9% downward over the last 60 days.View the entire Zacks Rank #5 List. Only $1 to See All Zacks' Buys and Sells We're not kidding. Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportAlliance Resource Partners, L.P. (ARLP) : Free Stock Analysis ReportAgios Pharmaceuticals, Inc. (AGIO) : Free Stock Analysis ReportAir France-KLM SA (AFLYY) : Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags StocksInvestingHow to Invest Zacks Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com. More articles by this source-> Stocks mentioned ARLP AGIO AFLYY More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Read Original

Tags

drug-discovery

Source Information

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.